1-15 of 15
Authors: C. Arajol
Journal Article
P202 Performance characteristics of serum FGF19 measurement compared with the Se-HCAT retention test in the diagnosis of bile acid diarrhoea in Crohn’s Disease Free
Journal of Crohn's and Colitis, Volume 16, Issue Supplement_1, January 2022, Pages i262–i263, https://doi.org/10.1093/ecco-jcc/jjab232.329
Published: 21 January 2022
Journal Article
P264 Impact of the HLA-DQ1*05 alelle on the initial response to infliximab in patients with Inflammatory Bowel Disease Free
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Pages S301–S302, https://doi.org/10.1093/ecco-jcc/jjab076.390
Published: 27 May 2021
Journal Article
P711 Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to adalimumab in patients with Crohn’s disease Free
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S574, https://doi.org/10.1093/ecco-jcc/jjz203.839
Published: 15 January 2020
Journal Article
P774 Low adhesion to latent tuberculosis (TB) screening recommendations in inflammatory bowel disease (IBD) patients: Results of the INFEII registry of GETECCU Free
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S614–S615, https://doi.org/10.1093/ecco-jcc/jjz203.902
Published: 15 January 2020
Journal Article
P642 Serum adalimumab levels measured between days 9 and 13 from drug injection can be interpreted clinically in a similar way to trough levels in patients with inflammatory bowel disease Free
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S532, https://doi.org/10.1093/ecco-jcc/jjz203.770
Published: 15 January 2020
Journal Article
P645 Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S441, https://doi.org/10.1093/ecco-jcc/jjy222.769
Published: 25 January 2019
Journal Article
P635 Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to infliximab in patients with inflammatory bowel disease Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S435–S436, https://doi.org/10.1093/ecco-jcc/jjy222.759
Published: 25 January 2019
Journal Article
P318 Association between faecal calprotectin values and infliximab trough levels in inflammatory bowel disease patients Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Pages S261–S262, https://doi.org/10.1093/ecco-jcc/jjx180.445
Published: 16 January 2018
Journal Article
P740 Efficacy and safety of vedolizumab in inflammatory bowel disease: Real-life experience Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Page S486, https://doi.org/10.1093/ecco-jcc/jjx180.867
Published: 16 January 2018
Journal Article
P761 IFX dose-escalation strategy based on a population PK model in IBD patients with secondary loss of response Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Page S496, https://doi.org/10.1093/ecco-jcc/jjx180.888
Published: 16 January 2018
Journal Article
P339 Crohn’s disease and self-monitoring through a mobile App: The Medicrohn study Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Page S273, https://doi.org/10.1093/ecco-jcc/jjx180.466
Published: 16 January 2018
Journal Article
P631 Treatment of established post-operative recurrence of Crohn’s disease with anti-TNF agents: Preliminary data of a multicentre, nationwide study Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Pages S428–S429, https://doi.org/10.1093/ecco-jcc/jjx180.758
Published: 16 January 2018
Journal Article
P546 Which are the optimal adalimumab trough levels associated with biological remission in patients with inflammatory bowel disease? Get access
Journal of Crohn's and Colitis, Volume 11, Issue suppl_1, February 2017, Page S358, https://doi.org/10.1093/ecco-jcc/jjx002.670
Published: 26 January 2017
Journal Article
P170 Planar radiolabelled white cell scintigraphy and Technetium-99m-HMPAO labeled leukocyte single photon emission computed tomography (SPECT) for assessing endoscopic remission in ulcerative colitis Get access
Journal of Crohn's and Colitis, Volume 8, Issue Supplement_1, February 2014, Page S133, https://doi.org/10.1016/S1873-9946(14)60291-9
Published: 01 February 2014
Journal Article
P275 Bile acid malabsorption involvement in Crohn's disease symptoms. Its relationship with ROME III criteria Get access
Journal of Crohn's and Colitis, Volume 8, Issue Supplement_1, February 2014, Pages S177–S178, https://doi.org/10.1016/S1873-9946(14)60396-2
Published: 01 February 2014
